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Retinopathy of prematurity (ROP) is a complex disease of the developing retinal vasculature in premature infants. ROP continues to be an important cause of potentially 
preventable blindness worldwide. It is believed to account for 
6-18% of the childhood blindness in developed countries [1]. 
Neonates born before 32 weeks of gestation are at risk of 
developing ROP. However, preterm infants born at 32 weeks 
or later can develop severe ROP if they have been sick or they 
require oxygen therapy. Recent advances in neonatal care in 
the last decade, have improved the survival rates for premature 
infants.
In India 28 million children are born, out of which 3.5 million 
are preterm and lot of them would not survive but now they are 
surviving [2]. Earlier Indian studies have shown that the incidence 
of ROP varies from 38 to 51.9% among low birth weight (LBW) 
babies [3-5]. However, more recent studies have shown a lower 
rate of ROP ranging from 13 to 30% [6-10]. The challenge in India 
is that a large number of neonatal intensive care units (NICUs) 
don’t have an effective ROP screening strategy and there is a need 
for an effective screening strategy for every NICU and Special 
Newborn Care Unit (SNCU).
Government of India under its National Health Mission and 
the Rashtriya Bal Swasthya Karyakram (RBSK) has set up a 
task force to set up the program for ROP screening across the 
whole country. Under RBSK scheme, ROP is included in the 
list of congenital defects for which a newborn will be screened. 
The Union Government under its RBSK is working toward 
establishing 634 SNCUs that are expected to provide ROP 
screening as a part of the essential newborn care for preterms. 
There is scarce data available for ROP in Rajasthan. Therefore, 
the current study has been conducted to bring out the incidence 
of ROP in high-risk neonates admitted in Jawaharlal Nehru 
Hospital, Ajmer, and the risk factors associated with the 
disease.
MATERIALS AND METHODS
This prospective study was conducted in the Department of 
Pediatrics and Ophthalmology, between January 2016 and 
July 2016. First, 100 neonates who are born of gestational age 
<32 weeks and weighing <1500 g or selected preterm neonates 
with a BW between 1501 and 2000 g with risk factors were 
included in the study. The risk factors included were need of 
cardiorespiratory support, need of supplemental oxygen (>21% 
oxygen concentration), need for surfactant therapy, apnea of 
prematurity, anemia (asymptomatic neonates with hematocrit 
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<21% or hematocrit <36% and requiring >35% oxygen 
concentration), intraventricular hemorrhage, respiratory distress, 
and culture proven neonatal sepsis. Clinically unstable newborn 
and neonates whose parents did not give consent for screening 
were excluded from the study. The plan for this study was 
approved by the Institutional Ethical Committee.
Ophthalmological Examination
Neonates admitted in NICU were screened by trained 
ophthalmologist in the neonatal unit itself under the supervision 
of attending pediatrician. Discomfort to the baby was minimized 
by pre-treatment of the eyes with a topical proparacaine screening 
of ROP involves indirect ophthalmoscopy using 20D or 28/30D 
lens by an experienced ophthalmologist.
Demographic profile and risk factors of the patient were 
recorded in a structured pro forma. Ophthalmological notes 
were made after each ROP examination, detailing zone, stage, 
and extent in terms of clock hours of any ROP and the presence 
of any preplus or plus disease. These notes also included the 
recommendation for the timing of the next examination and were 
kept with the baby’s medical record.
The stage of ROP was assessed as per the international 
classification of ROP which describes the location (Zone), extent 
(Clock hours), and severity (Stage) of the disease [11]. The 
severity of ROP was classified on the basis of early treatment for 
ROP (ETROP) study into severe or Type 1 ROP (which require 
intervention) and nonsevere or Type 2 ROP (lesser stages of ROP 
which require follow-up) [12]. Type 1 ROP and Type 2 ROP 
according to ETROP study are:
• Type 1 ROP
 • Zone 1, any stage ROP with plus disease
 • Zone 1, Stage 3 ROP without plus disease
 • Zone 2, Stage 2, 3 ROP with plus disease
• Type 2 ROP
 • Zone 1, Stage 1 or 2 ROP without plus disease
 • Zone 2, Stage 3 ROP without plus disease
A first screening examination was carried out at 32 weeks 
of gestation or 4 weeks of age, whichever was later. 
Follow-up examinations were recommended by the examining 
ophthalmologist on the basis of retinal findings: The neonates 
whose ROP requiring peripheral retinal ablation were referred 
expeditiously to higher center as the procedure needs to be 
conducted within 72 h to improve structural outcome.
All data were entered into a spreadsheet and analyzed using 
SPSS or MedCalc. Univariate and multivariate logistic regression 
was done to determine the risk factors for the development of 
any ROP. p=0.05 or less was considered statistically significant. 
Relative risk and 95% confidence intervals were calculated for 
determining the independent risk factors.
RESULTS
The current study revealed that the incidence of ROP in out of 100 
high-risk neonates was 19%. In this study, there were a total of 
51 male infants (51%) and 49 female infants (49%) out of which 
12 male (63.15%) and 7 female (36.84%) infants developed ROP. The 
incidence of ROP was 66.67% in babies <1000 g, 18.75% in babies 
between 1000 and 1500 g, and 10% in babies between 1501 and 
2000 g. The mean weight of babies having ROP was 1231.05±282.4 
g while the mean weight of babies without ROP was 1452.47±277.54 
g. The incidence of ROP was 100% in babies <28 weeks, 17.39% in 
babies between 28 and 32 weeks, and 11.11% in babies >32 weeks 
gestational age (Table 1). Neonate <32 weeks gestational age 
developed severe ROP. 4% of the neonates had severe ROP while 
15% had non-severe ROP as per ETROP classification. 8 neonates 
developed Stage 1 ROP (42.11%), 7 developed Stage 2 (36.84%), 
and 4 neonates developed Stage 3 ROP (21.05%) in which 1 neonate 
was Stage 3 ROP with plus disease (5.25%) (Table 2).
The risk factors found to be associated with occurrence of 
ROP on univariate analysis were lower gestation (p=0.0001), birth 
weight (p<0.001), oxygen therapy (p<0.001), and mechanical 
ventilation (p<0.01), culture proven sepsis (p<0.05), anemia 
requiring packed cell transfusion (p<0.001), intraventricular 
hemorrhage (p<0.05), apnea (p<0.05), and respiratory distress 
syndrome (RDS) (p<0.0001) (Table 3)..The mean duration of 
supplemental oxygen therapy (FiO2 >21%) was 8.94±8.4 days 
in ROP cases whereas, in non-ROP cases, it was 3.09±3.78 days. 
The mean duration of ventilation was 3±3.22 days in ROP cases 
whereas, in non-ROP cases, it was 0.59±1.44 days. BW <1000 g 
(p<0.01) and gestational age <28 weeks (p<0.001) were found to 
be important risk factors for ROP. Mean BW associated with ROP 
was 1231 g (95% confidence interval [CI]: 666 – 1795 g) compared 
to 1452 g (95% CI: 897 – 2007 g) for those without ROP.
On multivariate analysis, factors independently found to be 
associated with ROP were LBW and low gestational age (Table 4). 
4 (21.05%) neonates in this study developed severe ROP for 
which they were referred to the higher center for peripheral retinal 
ablation. Rest 15 (78.95%) neonates who developed ROP did not 
require intervention and were followed till ROP regression or 
vascularization of the peripheral retina.











<1000 6 4 (66.67) 2 (33.33) 0.0005
1000-1500 64 12 (18.75) 52 (81.25)
1501-2000 30 3 (10.00) 27 (90.00)
Gestational 
age in weeks
<28 4 4 (100.0) 0 (0.00) 0.0001
28-32 69 12 (17.39) 57 (82.60)
>32 27 3 (11.11) 24 (88.88)
ROP: Retinopathy of prematurity
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DISCUSSION
ROP continues to be an important cause of potentially preventable 
blindness worldwide. Recent advances in neonatal care in the last 
decade, have improved the survival rates for premature infants. 
Consequently, the incidence of ROP has increased in parallel. 
ROP is under constant epidemiological study around the world. 
Early identification of retinal damage and the institution of 
appropriate treatment prevent blindness and offer child better 
overall development. We have done this study to know the 
incidence of ROP in our institute.
In our study, the incidence of ROP was 19% and Type 1 ROP 
was 4%. In an earlier study by Gopal et al. [3], the incidence 
of ROP was found to be 38%, and threshold ROP was 16%. 
Maheshwari et al. [4] found 20% incidence of ROP (threshold 
ROP 9.1%) while Rekha et al. [5] found 46% (threshold ROP 
9%) and Chaudhari et al. [7] reported 22.3% incidence of ROP 
(threshold ROP 7.4%). However, Aggarwal et al. [9] and Prasad 
et al. [8] found incidence to be 32% (Type 1-2.6%) and 13% 
(Type 1-3%), respectively.
As regard the effect of low gestational age on the occurrence 
of ROP, our study found that it is a significant risk factor in ROP 
on univariate regression. This was in agreement with the results 
of studies conducted by Shah et al. [13], Karna et al. [14], and 
Fortes et al. [15]. This study found a significant relationship 
between gestational age and the severity of ROP; this was in 
Table 2: Distribution of cases according to severity of ROP according to ETROP study
Zone Zone Plus disease Classification as per ETROP Number Severity of ROP
Non-severe Severe
1 Stage 1 + Type 1
˗ Type 2 4 4
Stage 2 + Type 1
˗ Type 2 3 3
Stage 3 + Type 1 1 1
˗ Type 1 3 3
2 Stage 1 +
˗ 2 2
Stage 2 + Type 1
˗ 3 3
Stage 3 + Type 1
˗ Type 2






Total 19 15 4
ETROP: Early treatment for retinopathy of prematurity, ROP: Retinopathy of prematurity
Table 3: Association of ROP with risk factors
Risk factors Total cases (n=100) Number (%) p value
Cases with ROP (n=19) Cases without ROP (n=81)
Oxygen given 55 17 (89.47) 38 (46.91) 0.0007
Oxygen not given 45 2 (10.53) 43 (53.09)
Ventilation done 25 10 (52.63) 15 (18.52) 0.0019
Ventilation not done 75 9 (47.37) 66 (81.48)
Sepsis present 23 8 (42.10) 15 (18.52) 0.028
Sepsis absent 77 11 (57.89) 66 (81.48)
RDS present 43 14 (73.68) 29 (35.80) 0.0009
RDS absent 67 5 (26.31) 62 (76.54)
Apnea present 23 8 (42.10) 15 (18.51) 0.027
Apnea absent 77 11 (57.89) 66 (81.48)
PCV given 21 10 (47.61) 11 (52.38) 0.0871
PCV not given 79 9 (11.37) 70 (88.60)
ROP: Retinopathy of prematurity, RDS: Respiratory distress syndrome, PCV: Packed cell volume
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agreement with other studies showing that lower gestational age 
was significantly associated with severe ROP [13,15]. In our study 
using multivariate analysis, BW and gestational age emerged as 
independent risk factors. Similar results were found by Kim [16]. 
However, other studies have failed to find these as independent 
risk factors.
Our study revealed insignificant relationship between sex and 
occurrence of ROP, in contrast to Darlow et al. [17] and Aggarwal 
et al. [9] who found that male sex is a significant risk factor. Our 
study found a significant relationship between the occurrence of 
ROP and use of oxygen therapy on univariate analysis. The same 
result was drawn by Chaudhari et al. [7], Prasad et al. [8], and 
Gupta et al. [18]. On the other hand, Palmer [19] and Aggarwal 
et al. [9] reported that oxygen therapy was a non-significant factor 
for the occurrence of ROP. They reported that ROP may develop 
in cases that did not receive oxygen therapy. In our study, 2 out 
of 19 neonates developed ROP had not received supplemental 
oxygen. Our study found that mechanical ventilation was 
significant risk factors for ROP on univariate analysis and this 
agreed with Shah et al. [13] and Chaudhari et al. [7] and explained 
by the increased exposure to oxygen. However, Murthy and 
Nagendra [20] observed that ventilator support and continuous 
positive airway pressure were not significantly associated with 
the development of ROP.
Our study found that the packed cell transfusions are a 
significant risk factor for the development of ROP, and this 
agreed with Chaudhari et al. [7], Dutta et al. [21], and Rekha and 
Battu [5]. This can be explained by the fact that, adult red blood 
cells are rich in 2,3-diphosphoglycerate and adult hemoglobin 
which binds less firmly to oxygen, thus releasing excess oxygen 
to the retinal tissue. While Hirano et al. [22] stated that it is 
controversial and iron overload rather than number of transfusions 
may contribute to the development of ROP. However, our study 
did not find packed cell transfusion as an independent risk factor 
in contrast with Hakeem et al. [23] and Datta S. Our study found 
that sepsis was significantly associated with the development of 
ROP. This was in agreement with Shah et al. [13] and Vinekar 
et al. [10] which may be due to the effect of endotoxin on retinal 
blood vessels. On the other hand, this was in disagreement with 
the results of Chaudhari et al. [7].
Our study showed a significant relationship between apnea 
and occurrence of ROP. This was in agreement with Rekha 
and Battu [5], Aggarwal et al. [9], Gupta et al. [18], Chaudhari 
et al. [7], and Prasad et al. [8] and was attributed to hypoxia of 
retinal vasculature leading to stoppage of normal angiogenesis 
followed by neovascularization. However, Kim et al. found apnea 
as an independent risk factor for ROP which was not seen in this 
study. Our study showed a significant association between RDS 
and occurrence of ROP. Taqui et al. [24] observed a significant 
relation between RDS and the development of ROP and related 
this to the fact that systemic hypoxia results in retinal hypoxia 
and more need for oxygen therapy. The limitation of our study is 
a small sample size of 100 neonates while the study provided data 
for incidence of ROP in Rajasthan which is not readily available.
CONCLUSION
Our study revealed that the incidence of ROP in sick neonates 
was 19%. 4% of neonate has severe ROP while 15% have non-
severe ROP. Significant risk factors were found to be LBW, low 
gestational age, supplemental oxygen, and mechanical ventilation, 
culture proven sepsis, anemia, apnea, and RDS.
Table 4: Multivariate logistic regression for various risk factors associate with occurrence of ROP
Risk factors Cases with ROP (n=19) Cases without ROP (n=81) Total (n=100) p value (multiple logistic regression)
Gender
Male 12 39 49 0.9399
Female 7 42 51
Birth weight is taken as a continuous variable 0.0042
Gestational age calculated by Ballard score as continuous variable 0.0098
Blood transfusion
PCV given 10 11 21 0.0871
Not given 9 70 79
Duration of supplemental oxygen taken as continuous variable in days 0.2697
Duration of ventilation taken as continuous variable in days 0.0867
Culture proven sepsis
Present 8 15 23 0.1647
Absent 11 66 77
Apnea
Apnea present 8 15 23 0.4280
Apnea absent 11 66 77
RDS
RDS present 14 29 43 0.8856
RDS absent 5 62 67
ROP: Retinopathy of prematurity, RDS: Respiratory distress syndrome, PCV: Packed cell volume
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